国产传媒

Our Company

two women in lab - who we are

Who We Are

We are a world-class team of scientists, drug developers, and manufacturing experts who are united in our shared goal of finding in vivo solutions to fulfill the promise of CAR T cell therapies for every patient in need.聽

Leadership

Co-founder & Chief Executive Officer
He/Him/His
Co-founder & Chief Technical Officer
He/Him/His
Chief Financial Officer
Chief Legal Officer
He/Him/His
Chief Medical Officer
SVP, Head of Research
He/Him/His
Sally Dyer
SVP, General Manager, Colorado Operations
She/Her/Hers
Jacob Garcia
SVP, Clinical Operations & Development
Jennifer Lester
SVP, IT & Informatics
She/Her/Hers
VP, Business Development & Operations
Chris Lewis
VP, Quality
He/Him/His
Geoff Quinn
VP, Corporate Operations
He/Him/His
VP, Human Resources
She/Her/Hers
Branden Salinas
VP, Process Sciences
He/Him/His
VP, CMC Strategy

Board of Directors

Chairman of the Board
Co-founder & Chief Executive Officer
MPM Capital
Qiming Venture Partners USA
DCVC Bio
Co-founder & Managing Partner, Double Point Ventures
SoftBank

Scientific Advisory Board

Purdue University, Co-founder, 国产传媒, Scientific Advisory Board Co-chair
Seattle Children's Hospital, Co-founder, 国产传媒, Scientific Advisory Board Co-chair
Fred Hutch Endowed Chair for Cell and Gene Therapy
Ben Towne Center for Childhood Cancer
Henry Pitot Professor of Pathology & Laboratory Medicine, University of Wisconsin, Madison

Current Investors

DCVC Bio
Casdin Capital
CORMORANT ASSET MANAGEMENT
EMERSON COLLECTIVE
Qiming Venture Partners
MPM
Presight Capital
RTW Investments
SoftBank Group
Temasek

Together, we are advancing in vivo CAR T cell therapies to fulfill the promise of this treatment option to every patient in need. Learn more about our team of experts.